Chemed (CHE) – Investment Analysts’ Recent Ratings Changes

by · The Markets Daily

Chemed (NYSE: CHE) recently received a number of ratings updates from brokerages and research firms:

  • 8/1/2026 – Chemed was upgraded by Wall Street Zen from “hold” to “strong-buy”.
  • 7/31/2026 – Chemed had its price target raised by Oppenheimer Holdings, Inc. from $500.00 to $590.00. They now have an “outperform” rating on the stock.
  • 7/30/2026 – Chemed had its price target raised by Royal Bank Of Canada from $436.00 to $548.00. They now have a “sector perform” rating on the stock.
  • 7/29/2026 – Chemed had its “neutral” rating reaffirmed by Bank of America Corporation.
  • 7/17/2026 – Chemed was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
  • 7/9/2026 – Chemed had its price target raised by Bank of America Corporation from $450.00 to $510.00. They now have a “neutral” rating on the stock.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a $0.70 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s payout ratio is presently 12.05%.

Insider Activity

In other Chemed news, Director Patrick P. Grace sold 190 shares of the business’s stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the transaction, the director owned 3,533 shares in the company, valued at $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 3,537 shares of company stock worth $1,782,654. 3.33% of the stock is currently owned by corporate insiders.

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Stories